GATEWAY FOR CANCER RESEARCH
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$21,075,932
Investments
72%
Receivables (Non-Related)
13%
Cash & Equivalents
13%
Other Assets
2%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$7,946,478
Grants Payable
96%
Payables & Accruals
3%
Deferred Revenue
<1%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$5,579,742
$2,701,783
-52%
Receivables (Non-Related)
$701,000
$2,775,000
+296%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$72,711
$37,869
-48%
Investments
$13,399,144
$15,178,351
+13%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
$509,343
$382,929
-25%
Total Assets
$20,261,940
$21,075,932
+4%
Liabilities
2023
2024
Change
Payables & Accruals
$250,794
$273,976
+9%
Grants Payable
$9,862,290
$7,650,009
-22%
Deferred Revenue
$25,575
$22,493
-12%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$0
-
-
Total Liabilities
$10,138,659
$7,946,478
-22%
Net assets
2023
2024
Change
Restricted Net Assets
$3,557,744
$5,834,496
+64%
Unrestricted Net Assets
$6,565,537
$7,294,958
+11%
Net assets
2023
2024
Change
Net assets
+$10,123,281
+$13,129,454
+30%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)